436 related articles for article (PubMed ID: 20822096)
1. Development of bimetallic titanocene-ruthenium-arene complexes as anticancer agents: relationships between structural and biological properties.
Pelletier F; Comte V; Massard A; Wenzel M; Toulot S; Richard P; Picquet M; Le Gendre P; Zava O; Edafe F; Casini A; Dyson PJ
J Med Chem; 2010 Oct; 53(19):6923-33. PubMed ID: 20822096
[TBL] [Abstract][Full Text] [Related]
2. Multinuclear cytotoxic metallodrugs: physicochemical characterization and biological properties of novel heteronuclear gold-titanium complexes.
Wenzel M; Bertrand B; Eymin MJ; Comte V; Harvey JA; Richard P; Groessl M; Zava O; Amrouche H; Harvey PD; Le Gendre P; Picquet M; Casini A
Inorg Chem; 2011 Oct; 50(19):9472-80. PubMed ID: 21875041
[TBL] [Abstract][Full Text] [Related]
3. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands.
Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK
J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622
[TBL] [Abstract][Full Text] [Related]
4. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
[TBL] [Abstract][Full Text] [Related]
5. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
[TBL] [Abstract][Full Text] [Related]
6. Coordinatively diverse ortho-phosphinoaniline complexes of ruthenium and isolation of a putative intermediate in ketone transfer hydrogenation catalysis.
Hounjet LJ; Bierenstiel M; Ferguson MJ; McDonald R; Cowie M
Inorg Chem; 2010 May; 49(9):4288-300. PubMed ID: 20364836
[TBL] [Abstract][Full Text] [Related]
7. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
[TBL] [Abstract][Full Text] [Related]
8. Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity.
Auzias M; Therrien B; Süss-Fink G; Stepnicka P; Ang WH; Dyson PJ
Inorg Chem; 2008 Jan; 47(2):578-83. PubMed ID: 18085776
[TBL] [Abstract][Full Text] [Related]
9. Selenoquinones stabilized by ruthenium(II) arene complexes: synthesis, structure, and cytotoxicity.
Dubarle-Offner J; Clavel CM; Gontard G; Dyson PJ; Amouri H
Chemistry; 2014 May; 20(19):5795-801. PubMed ID: 24668791
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and in vitro evaluation of novel ruthenium(II) eta6-arene imidazole complexes.
Vock CA; Scolaro C; Phillips AD; Scopelliti R; Sava G; Dyson PJ
J Med Chem; 2006 Sep; 49(18):5552-61. PubMed ID: 16942028
[TBL] [Abstract][Full Text] [Related]
12. Ruthenium-arene complexes of curcumin: X-ray and density functional theory structure, synthesis, and spectroscopic characterization, in vitro antitumor activity, and DNA docking studies of (p-cymene)Ru(curcuminato)chloro.
Caruso F; Rossi M; Benson A; Opazo C; Freedman D; Monti E; Gariboldi MB; Shaulky J; Marchetti F; Pettinari R; Pettinari C
J Med Chem; 2012 Feb; 55(3):1072-81. PubMed ID: 22204522
[TBL] [Abstract][Full Text] [Related]
13. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
Yadav M; Singh AK; Maiti B; Pandey DS
Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
[TBL] [Abstract][Full Text] [Related]
14. Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds.
Casini A; Gabbiani C; Sorrentino F; Rigobello MP; Bindoli A; Geldbach TJ; Marrone A; Re N; Hartinger CG; Dyson PJ; Messori L
J Med Chem; 2008 Nov; 51(21):6773-81. PubMed ID: 18834187
[TBL] [Abstract][Full Text] [Related]
15. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
[TBL] [Abstract][Full Text] [Related]
16. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
[TBL] [Abstract][Full Text] [Related]
17. Ruthenium(II)-arene complexes with functionalized pyridines: synthesis, characterization and cytotoxic activity.
Grgurić-Sipka S; Ivanović I; Rakić G; Todorović N; Gligorijević N; Radulović S; Arion VB; Keppler BK; Tesić ZLj
Eur J Med Chem; 2010 Mar; 45(3):1051-8. PubMed ID: 20053483
[TBL] [Abstract][Full Text] [Related]
18. Selective, cytotoxic organoruthenium(II) full-sandwich complexes: a structural, computational and in vitro biological study.
Loughrey BT; Cunning BV; Healy PC; Brown CL; Parsons PG; Williams ML
Chem Asian J; 2012 Jan; 7(1):112-21. PubMed ID: 22095971
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, molecular structure, and C-C coupling reactions of carbeneruthenium(II) complexes with C5H5Ru(=CRR') and C5Me5Ru(=CRR') as molecular units.
Braun T; Münch G; Windmüller B; Gevert O; Laubender M; Werner H
Chemistry; 2003 Jun; 9(11):2516-30. PubMed ID: 12794894
[TBL] [Abstract][Full Text] [Related]
20. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]